Coronary Artery Disease (CAD). Chronic ischaemic heart disease, unspecified
Conditions
Interventions
Intervention 1: Control group: The group that consumes a 500 mg capsule containing cellulose .Daily two capsules for 3 months.This capsule is prepared by the Essential Oil Pharmaceutical Company. Inte
Sponsors
Rafsanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: coronary artery stenosis above 50% at least in one of the major coronary arteries and clinical stability, based on the Gensini criteria the willingness to participate in the study Age 40 and older
Exclusion criteria
Exclusion criteria: include allergy to green tea or components and green tea products the use of any antioxidant supplement daily intake of green tea before and during the study follow a special diet participate in another study alcohol intake candidate for surgery Coronary artery bypass graft (CABG) pregnancy lactation perceptual disorders unstable angina arrhythmia Diseases such as kidney and urinary tract and osteoporosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Re-admission. Timepoint: Before intervention and 3 months after study. Method of measurement: Number of patients re-admission.;Systolic blood pressure. Timepoint: Before intervention and 3 months after study. Method of measurement: Digital barometer.;Diastolic blood pressure. Timepoint: Before intervention and 3 months after study. Method of measurement: Digital barometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: Before intervention and 3 months after study. Method of measurement: SF36 quality of life questionnaire.;Triglycerides. Timepoint: Before intervention and 3 months after study. Method of measurement: Autoanalysis machine.;Low density lipoprotein. Timepoint: Before intervention and 3 months after study. Method of measurement: Autoanalysis machine.;High density lipoprotein. Timepoint: Before intervention and 3 months after study. Method of measurement: Autoanalysis machine.;Cholesterol. Timepoint: Before intervention and 3 months after study. Method of measurement: Autoanalysis machine.;Blood sugar. Timepoint: Before intervention and 3 months after study. Method of measurement: Autoanalysis machine.;Total capacity antioxidant. Timepoint: Before intervention and 3 months after study. Method of measurement: German Zellbio chromogen kit and Spectrophotometer.;Anti-Inflammatory Cytokine Level IL-10. Timepoint: Before intervention and 3 months after study. Method of measurement: German-made Zellbio kits and Enzyme-linked immunosorbent assay (ELISA).;Weight. Timepoint: Before intervention and 3 months after study. Method of measurement: Digital Scale.;Body mass index. Timepoint: Before intervention and 3 months after study. Method of measurement: Using the formula: Weight (kg) per square meter height.;Waist circumference. Timepoint: Before intervention and 3 months after study. Method of measurement: Strip meter.;Wrist circumference. Timepoint: Before intervention and 3 months after study. Method of measurement: Strip meter.;Abdominal circumference. Timepoint: Before intervention and 3 months after study. Method of measurement: Strip meter.;Heart rate. Timepoint: Before intervention and 3 months after study. Method of measurement: Digital monitor device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Hassanshahi Raviz
Rafsanjan University of Medical Sciences
Outcome results
None listed